The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
In a first-of-its-kind probe in the medical-devices sector, the European Commission opened an antitrust investigation into Align Technology, the maker of Invisalign, over its sales strategy for iTero scanners. The probe follows a competitor's complaint, raising questions about the company's dominance in the clear-aligner market.
Align Technology is the global leader in clear aligners, commanding a large market share with Invisalign, alongside its iTero intra-oral scanners used in dental clinics. This is the EU's first formal antitrust investigation in the medical-devices industry, signaling heightened scrutiny of competitive practices in the sector.
Sign in to access this content
Sign InAlign Technology has not yet commented. Investors will watch the investigation's progress, including potential fines or changes to the company's sales strategy. The stock trades on Nasdaq under the ticker ALGN.